Canada Research Chair in Neuroepidemiology and Multiple Sclerosis and Professor at the University of British Columbia, Vancouver, Canada in the Faculty of Medicine, Division of Neurology. Dr Tremlett’s research program is funded through operating and foundation grants from the Canadian Institutes of Health Research (CIHR), the MS Society of Canada, the MS Scientific Research Foundation, the US National MS Society among others. Trained in pharmacoepidemiology and multiple sclerosis with a PhD from Cardiff University, UK. Heads the Tremlett Lab and the Epidemiology in Multiple Sclerosis (MS) research program with the vision of fostering excellence in multi-disciplinary clinical and epidemiological research to advance treatment-related knowledge and improve outcomes in those with MS. Ongoing research studies include: the MS prodrome, safety and effectiveness of the disease-modifying drugs for MS; pharmacogenomics; risk of MS in special populations; impact of comorbidities on MS outcomes; and the gut microbiome and MS.
Over 180 peer-reviewed papers, view via PubMed: https://www.ncbi.nlm.nih.gov/pubmed/?term=Tremlett+H%5BAuthor%5D
Role: Epidemiologist/Research Associate
Previous Academic Training: PhD in Epidemiology (University of British Columbia), MSc in Behavioural Neuroscience (University of Calgary), BSc (Joint Hons.) in Zoology and Psychology (University College Swansea, University of Wales)
Research interests and current projects include: the epidemiology of multiple sclerosis (MS) (survival and mortality, incidence and prevalence, co-morbidity, natural course and disease progression, risk factors for MS); the short- and long-term benefits and risks of MS disease-modifying therapies; observational study design (including cohort, case control and nested case control); pharmacoepidemiology; biostatistics; health measurement; health behaviour; and questions related gender and health.
Funded through grants or awards from the MS Society of Canada, the Canadian Institutes of Health Research, the National MS Society (U.S.) and the Fondation ARSEP (France).
Role: Statistician/Research Associate
Previous Academic Training: PhD in Statistics (UBC)
Research interests: MS and related co-morbidities, real-world drug effectiveness and safety, analysis of administrative data, and statistical learning of high dimensional administrative data, microbiome in MS
Current projects: DRUMS: Prescription Drug Safety and Effectiveness in Multiple Sclerosis, From bugs to brains: the gut microbiome in pediatric MS